Catalyst Wire Dossier Catalyst Wire Dossier

Phentolamine Mesylate Ophthalmic Solution

phentolamine mesylate · Ocuphire Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Phentolamine Mesylate Ophthalmic Solution, covering 2019-08-01 to 2019-08-01. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances [Phase 2]

See pricing